BCL2 and COVID-19: Within the PI3K-AKT pathway framework, AKT1 enhances the anti-apoptotic function of BCL2 gene by phosphorylating and inhibiting pro-apoptotic proteins, highlighting the synergistic role of these two genes in regulating the immune response to sepsis and COVID-19 [46,50].